This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Hormone-Sensitive Prostate Cancer

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Hormone-Sensitive Prostate Cancer Means

Hormone-sensitive prostate cancer is a form of prostate cancer that needs male hormones called androgens to grow. The main androgen is testosterone, which is mostly produced in the testicles. These hormones normally help the prostate gland function but can also encourage prostate cancer cells to multiply. When prostate cancer is hormone-sensitive, it means the cancer’s growth depends on these hormones. Lowering androgen levels or blocking their effects can slow or stop the cancer’s growth.

Why This Concept Matters in Cancer Care

This concept is important because it guides treatment decisions. Many early-stage prostate cancers are hormone-sensitive, so hormone therapies that reduce androgen levels or block their action can be effective. These treatments, often called androgen deprivation therapy (ADT), may include surgery to remove the testicles or medications that lower hormone production or block hormone effects. Knowing if the cancer is hormone-sensitive helps doctors choose treatments and predict how well they might work.

What Patients Might See or Hear

You might hear your cancer described as hormone-sensitive, androgen-dependent, androgen-sensitive, or castrate-sensitive prostate cancer. These terms all mean the cancer needs androgens to grow. This usually means hormone therapy is a recommended treatment. You might see these terms in medical reports, treatment plans, or when your doctor explains your options. Understanding this can help you follow why hormone therapy is suggested and what to expect.

What the Term Does Not Automatically Mean

Being hormone-sensitive does not mean the cancer will always respond to hormone therapy. Over time, some prostate cancers can become castration-resistant, meaning they grow even when androgen levels are very low. This change requires different treatments. So, hormone-sensitive prostate cancer describes how the cancer behaves now but does not guarantee how it will act in the future.

How Doctors Use This Concept

Doctors use the idea of hormone sensitivity when diagnosing and planning treatment. Tests like biopsies and imaging help determine if the cancer is likely to respond to hormone therapy. This information is included in medical reports and helps guide decisions about hormone therapy, surgery, radiation, or other treatments. It also helps doctors monitor how well the cancer responds and adjust treatment if needed.

Common Sources of Confusion and Related Terms

Terms like hormone-sensitive, androgen-dependent, androgen-sensitive, and castrate-sensitive prostate cancer all describe cancers that rely on male hormones. These different names can be confusing but generally mean the same thing. It’s helpful to know they refer to the cancer’s current hormone dependence. This understanding can reduce confusion and anxiety when hearing different terms in medical reports or conversations.

Safety and Next Steps

This information is educational and does not decide what is safe or appropriate for any individual patient. If you see this term in your medical records or hear it from your care team, the best next step is to ask your doctor or nurse what it means for your specific situation. They can explain how it relates to your diagnosis, treatment options, and what to expect going forward.

Sources

Public source information used for this glossary entry includes: